Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital of Zhejiang UniversityActive in the last 2 years

Hao Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2169-115X; OpenAlex author ID A5083340325. Sources: OpenAlex.

Their work

Papers
5
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2019: 2 papers · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 1 paper

Papers 5

  1. Corrigendum: The role of microtubules in pancreatic cancer: therapeutic progress. Co-author DOI 10.3389/fonc.2024.1414456↗
  2. N6-methyladenosine methylation modification patterns reveal immune profiling in pancreatic adenocarcinoma. Co-author DOI 10.1186/s12935-022-02614-x↗
  3. The Role of Microtubules in Pancreatic Cancer: Therapeutic Progress. Co-author DOI 10.3389/fonc.2021.640863↗
  4. Excipient-free nanodispersion of 7-ethyl-10-hydroxycamptothecin exerts potent therapeutic effects against pancreatic cancer cell lines and patient-derived xeno… Co-author DOI 10.1016/j.canlet.2019.08.019↗
  5. GSK343 induces autophagy and downregulates the AKT/mTOR signaling pathway in pancreatic cancer cells. Co-author DOI 10.3892/etm.2019.7845↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Weilin Wang · 4 shared papers, 2019–2024 · strength 0.54
  2. Mugahed Abdullah Hasan Albahde · 3 shared papers, 2019–2024 · strength 0.46
  3. Dongkai Zhou · 2 shared papers, 2021–2024 · strength 0.37
  4. Qianhui Xu · 1 shared paper, 2022 · strength 0.20
  5. Rujun Xu · 1 shared paper, 2022 · strength 0.20
  6. Linshi Zhang · 2 shared papers, 2019 · strength 0.18
  7. Jiarong Zhou · 2 shared papers, 2019 · strength 0.18
  8. Rong Du · 1 shared paper, 2019 · strength 0.08
  9. Yuan Ding · 1 shared paper, 2019 · strength 0.08
  10. Quan Zhou · 1 shared paper, 2019 · strength 0.08
  11. Youqing Shen · 1 shared paper, 2019 · strength 0.08
  12. Huilin Zheng · 1 shared paper, 2019 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.